Expanded Access
Careers
Contact us
Company
Management team
Board of directors
Scientific Advisory Board
DefenCath™
About DefenCath™
LOCK-IT-100
Research & development
Taurolidine
Pipeline
Early science
Publications
Publications and presentations
In the news
Investors
Press releases
Analyst coverage
Corporate governance
SEC filings
FAQ
Presentations and events
ABOUT CRBSI
Home
>
Investors >
Press Release
CorMedix Inc. to Report Fourth Quarter 2022 Financial Results and Provide a Corporate Update
May 3, 2023
You are now leaving
cormedix.com
Would you like to proceed?
CONTINUE
Cancel
